Harbin Medisan Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Harbin Medisan Pharmaceutical has a total shareholder equity of CN¥2.2B and total debt of CN¥918.1M, which brings its debt-to-equity ratio to 42.3%. Its total assets and total liabilities are CN¥3.6B and CN¥1.5B respectively.
Key information
42.3%
Debt to equity ratio
CN¥918.06m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.16b |
| Equity | CN¥2.17b |
| Total liabilities | CN¥1.45b |
| Total assets | CN¥3.62b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002900's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 002900's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥302.3M).
Debt to Equity History and Analysis
Debt Level: 002900 has more cash than its total debt.
Reducing Debt: 002900's debt to equity ratio has increased from 5.2% to 42.3% over the past 5 years.
Debt Coverage: 002900's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 002900's interest payments on its debt are well covered by EBIT.